Ha seleccionado la visión en Inglés
Descriptor en español: |
Dactinomicina
| ||||||
Descriptor en inglés: | Dactinomycin | ||||||
Descriptor en portugués: | Dactinomicina | ||||||
Descriptor en francés: | Dactinomycine | ||||||
Término(s) alternativo(s): |
Actinomycin Actinomycin D Cosmegen Cosmegen Lyovac Lyovac Cosmegen Lyovac, Cosmegen Lyovac-Cosmegen LyovacCosmegen Meractinomycin |
||||||
Código(s) jeráquico(s): |
D03.633.300.200 D04.345.566.252 D12.644.641.252 |
||||||
Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D003609 | ||||||
Nota de alcance: | A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) |
||||||
Calificadores permitidos: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Acción Farmacológica: |
Antibacterianos Antibióticos Antineoplásicos Inhibidores de la Síntesis de la Proteína Inhibidores de la Síntesis del Ácido Nucleico |
||||||
Número de registro: | 1CC1JFE158 | ||||||
Nombre CAS Tipo 1: | Actinomycin D | ||||||
Nota Pública de MeSH: | 66; ACTINOMYCIN was heading 1963-95 |
||||||
Nota de historia: | 66; ACTINOMYCIN was heading 1963-95 |
||||||
Identificador de DeCS: | 3628 | ||||||
ID del Descriptor: | D003609 | ||||||
Documentos indizados en la Biblioteca Virtual de Salud (BVS): | Haga clic aquí para acceder a los documentos de la BVS | ||||||
Fecha de establecimiento: | 01/01/1966 | ||||||
Fecha de entrada: | 01/01/1999 | ||||||
Fecha de revisión: | 24/05/2017 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Dactinomycin
- Concepto preferido
Actinomycin
- Más amplio
Cosmegen
- Más estrecho
UI del concepto |
M0005644 |
Nota de alcance | A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) |
Término preferido | Dactinomycin |
Término(s) alternativo(s) |
Actinomycin D Meractinomycin |
UI del concepto |
M0005643 |
Término preferido | Actinomycin |
UI del concepto |
M0354002 |
Término preferido | Cosmegen |
Término(s) alternativo(s) |
Cosmegen Lyovac Lyovac Cosmegen Lyovac, Cosmegen Lyovac-Cosmegen LyovacCosmegen |
Queremos sus comentarios sobre el nuevo sitio web de DeCS / MeSH
Lo invitamos a completar una encuesta que no tomará más de 3 minutos.
Ir a la encuesta